Bründl J, Breyer J, Burger M
Klinik für Urologie der Universität Regensburg, Caritas-Krankenhaus St. Josef, Landshuter Straße 65, 93053, Regensburg, Deutschland.
Urologe A. 2018 Sep;57(9):1048-1057. doi: 10.1007/s00120-018-0729-9.
The recent introduction of new diagnostic techniques has revolutionized uro-oncolgy. In addition to multiparametric magnetic resonance imaging (mpMRI), prostate-specific membrane antigen positron-emission tomography (PSMA-PET) plays an increasingly import role in daily practice. The introduction of three-dimensional (3D) printing technologies in the context of robot-assisted uro-oncological surgery represents a first step towards individualized 3D imaging. In the era of immunotherapy, imaging is challenged by new diagnostic criteria (iRECIST) and immune-related adverse effects.
近期新诊断技术的引入彻底改变了泌尿肿瘤学。除多参数磁共振成像（mpMRI）外，前列腺特异性膜抗原正电子发射断层扫描（PSMA-PET）在日常实践中发挥着越来越重要的作用。在机器人辅助泌尿肿瘤手术中引入三维（3D）打印技术是迈向个性化3D成像的第一步。在免疫治疗时代，成像面临着新的诊断标准（iRECIST）和免疫相关不良反应的挑战。
